Favre G - Search Results

1

Treatment of murine hepatocellular carcinoma using genetically modified cells to express interleukin-12.

Peron JM, Couderc B, Rochaix P, Douin-Echinard V, Asnacios A, Souque A, Voigt JJ, Buscail L, Vinel JP, Favre G. Peron JM, et al. Among authors: favre g. J Gastroenterol Hepatol. 2004 Apr;19(4):388-96. doi: 10.1111/j.1440-1746.2003.03295.x. J Gastroenterol Hepatol. 2004. PMID: 15012775

2

Reversion of transformed phenotype of human adenocarcinoma A549 cells by expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase complementary DNA.

Seronie-Vivien S, Pradines A, Couderc B, Clamagirand C, Berg D, Soula G, Favre G. Seronie-Vivien S, et al. Among authors: favre g. Cell Growth Differ. 1995 Nov;6(11):1415-23. Cell Growth Differ. 1995. PMID: 8562480

3

Preferential cytoplasmic localization of p34cdc2 in recurrent human squamous cell carcinoma after radiotherapy.

Cohen-Jonathan E, Toulas C, Rochaix P, Bachaud JM, Daly-Schveitzer N, Favre G. Cohen-Jonathan E, et al. Among authors: favre g. Radiat Res. 1997 Mar;147(3):277-83. Radiat Res. 1997. PMID: 9052672

4

Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells.

Couderc B, Zitvogel L, Douin-Echinard V, Djennane L, Tahara H, Favre G, Lotze MT, Robbins PD. Couderc B, et al. Among authors: favre g. Cancer Gene Ther. 1998 May-Jun;5(3):163-75. Cancer Gene Ther. 1998. PMID: 9622100

5

Enhancement of anti-tumor immunity by injection of fibroblasts genetically engineered to produce IL-12 and to express CD70.

Douin-Echinard V, Robbins PD, Lotze MT, Favre G, Couderc B. Douin-Echinard V, et al. Among authors: favre g. Adv Exp Med Biol. 1998;451:353-7. doi: 10.1007/978-1-4615-5357-1_55. Adv Exp Med Biol. 1998. PMID: 10026896 No abstract available.

6

The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status.

Douin-Echinard V, Bornes S, Rochaix P, Tilkin AF, Peron JM, Bonnet J, Favre G, Couderc B. Douin-Echinard V, et al. Among authors: favre g. Cancer Gene Ther. 2000 Dec;7(12):1543-56. doi: 10.1038/sj.cgt.7700268. Cancer Gene Ther. 2000. PMID: 11228533

7

In vivo induction of antitumor immunity and protection against tumor growth by injection of CD154-expressing tumor cells.

Grangeon C, Cormary C, Douin-Echinard V, Favre G, Couderc B, Tilkin-Mariamé AF. Grangeon C, et al. Among authors: favre g. Cancer Gene Ther. 2002 Mar;9(3):282-8. doi: 10.1038/sj.cgt.7700439. Cancer Gene Ther. 2002. PMID: 11896445

8

Increased expression of a COOH-truncated nucleophosmin resulting from alternative splicing is associated with cellular resistance to ionizing radiation in HeLa cells.

Dalenc F, Drouet J, Ader I, Delmas C, Rochaix P, Favre G, Cohen-Jonathan E, Toulas C. Dalenc F, et al. Among authors: favre g. Int J Cancer. 2002 Aug 20;100(6):662-8. doi: 10.1002/ijc.10558. Int J Cancer. 2002. PMID: 12209603

9

Involvement of CD70 and CD80 intracytoplasmic domains in the co-stimulatory signal required to provide an antitumor immune response.

Douin-Echinard V, Péron JM, Lauwers-Cancès V, Favre G, Couderc B. Douin-Echinard V, et al. Among authors: favre g. Int Immunol. 2003 Mar;15(3):359-72. doi: 10.1093/intimm/dxg038. Int Immunol. 2003. PMID: 12618480

10

Inhibition of Rho pathways induces radiosensitization and oxygenation in human glioblastoma xenografts.

Ader I, Delmas C, Bonnet J, Rochaix P, Favre G, Toulas C, Cohen-Jonathan-Moyal E. Ader I, et al. Among authors: favre g. Oncogene. 2003 Dec 4;22(55):8861-9. doi: 10.1038/sj.onc.1207095. Oncogene. 2003. PMID: 14654782

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

342 results

Search Page

Filters